Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 2018;6:15.

Article  PubMed  PubMed Central  Google Scholar 

Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388(10055):2023–38.

Article  CAS  PubMed  Google Scholar 

Salaffi F, Carotti M, Gasparini S, Intorcia M, Grassi W. The health-related quality of life in rheumatoid arthritis, ankylosing spondylitis, and psoriatic arthritis: a comparison with a selected sample of healthy people. Health Qual Life Outcomes. 2009;7:25.

Article  PubMed  PubMed Central  Google Scholar 

Appelt J, Baranowsky A, Jahn D, Yorgan T, Kohli P, Otto E, et al. The neuropeptide calcitonin gene-related peptide alpha is essential for bone healing. EBioMedicine. 2020;59: 102970.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keller J, Catala-Lehnen P, Huebner AK, Jeschke A, Heckt T, Lueth A, et al. Calcitonin controls bone formation by inhibiting the release of sphingosine 1-phosphate from osteoclasts. Nat Commun. 2014;5:5215.

Article  CAS  PubMed  Google Scholar 

Baranowsky A, Jahn D, Jiang S, Yorgan T, Ludewig P, Appelt J, et al. Procalcitonin is expressed in osteoblasts and limits bone resorption through inhibition of macrophage migration during intermittent PTH treatment. Bone Res. 2022;10(1):9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maleitzke T, Hildebrandt A, Dietrich T, Appelt J, Jahn D, Otto E, et al. The calcitonin receptor protects against bone loss and excessive inflammation in collagen antibody-induced arthritis. iScience. 2022;25(1):103689.

Article  CAS  PubMed  Google Scholar 

Maleitzke T, Hildebrandt A, Weber J, Dietrich T, Appelt J, Jahn D, et al. Proinflammatory and bone protective role of calcitonin gene-related peptide alpha in collagen antibody-induced arthritis. Rheumatology (Oxford). 2021;60(4):1996–2009.

Article  CAS  PubMed  Google Scholar 

Walsh DA, Mapp PI, Kelly S. Calcitonin gene-related peptide in the joint: contributions to pain and inflammation. Br J Clin Pharmacol. 2015;80(5):965–78.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wen ZH, Tang CC, Chang YC, Huang SY, Lin YY, Hsieh SP, et al. Calcitonin attenuates cartilage degeneration and nociception in an experimental rat model of osteoarthritis: role of TGF-beta in chondrocytes. Sci Rep. 2016;6:28862.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Becker KL, Nylen ES, White JC, Muller B, Snider RH Jr. Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors. J Clin Endocrinol Metab. 2004;89(4):1512–25.

Article  CAS  PubMed  Google Scholar 

Baranowsky A, Appelt J, Kleber C, Lange T, Ludewig P, Jahn D, et al. Procalcitonin exerts a mediator role in septic shock through the calcitonin gene-related peptide receptor. Crit Care Med. 2021;49(1):e41–52.

Article  CAS  PubMed  Google Scholar 

Sato H, Tanabe N, Murasawa A, Otaki Y, Sakai T, Sugaya T, et al. Procalcitonin is a specific marker for detecting bacterial infection in patients with rheumatoid arthritis. J Rheumatol. 2012;39(8):1517–23.

Article  CAS  PubMed  Google Scholar 

Delevaux I, Andre M, Colombier M, Albuisson E, Meylheuc F, Begue RJ, et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes? Ann Rheum Dis. 2003;62(4):337–40.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ng KJ, Yu HC, Huang Tseng HY, Hsu CW, Lu MC. Modestly elevated serum procalcitonin levels in patients with rheumatoid arthritis free of active infection. Medicina (Kaunas). 2020;56:10.

Google Scholar 

Liu Y, Shi J, Wang B, Zhou L, Zhou X, Du Y, et al. Combining calcitonin and procalcitonin and rheumatoid arthritis-related biomarkers improve diagnostic outcomes in early rheumatoid arthritis. Dis Markers. 2021;2021:6331994.

PubMed  PubMed Central  Google Scholar 

Hoff AO, Catala-Lehnen P, Thomas PM, Priemel M, Rueger JM, Nasonkin I, et al. Increased bone mass is an unexpected phenotype associated with deletion of the calcitonin gene. J Clin Invest. 2002;110(12):1849–57.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maleitzke T, Weber J, Hildebrandt A, Dietrich T, Zhou S, Tsitsilonis S, et al. Standardized protocol and outcome measurements for the collagen antibody-induced arthritis mouse model. STAR Protoc. 2022;3(4): 101718.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lu JT, Son YJ, Lee J, Jetton TL, Shiota M, Moscoso L, et al. Mice lacking alpha-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development. Mol Cell Neurosci. 1999;14(2):99–120.

Article  CAS  PubMed  Google Scholar 

Nandakumar KS, Svensson L, Holmdahl R. Collagen type II-specific monoclonal antibody-induced arthritis in mice: description of the disease and the influence of age, sex, and genes. Am J Pathol. 2003;163(5):1827–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lee H, Zahra D, Vogelzang A, Newton R, Thatcher J, Quan A, et al. Human C5aR knock-in mice facilitate the production and assessment of anti-inflammatory monoclonal antibodies. Nat Biotechnol. 2006;24(10):1279–84.

Article  CAS  PubMed  Google Scholar 

Rudd PA, Lim EXY, Stapledon CJM, Krishnan R, Herrero LJ. Pentosan polysulfate sodium prevents functional decline in chikungunya infected mice by modulating growth factor signalling and lymphocyte activation. PLoS ONE. 2021;16(9): e0255125.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kawamoto T, Shimizu M. A method for preparing 2- to 50-micron-thick fresh-frozen sections of large samples and undecalcified hard tissues. Histochem Cell Biol. 2000;113(5):331–9.

Article  CAS  PubMed  Google Scholar 

Tu J, Zhang Y, Kim S, Wiebe E, Spies CM, Buttgereit F, et al. Transgenic disruption of glucocorticoid signaling in osteoblasts attenuates joint inflammation in collagen antibody-induced arthritis. Am J Pathol. 2016;186(5):1293–301.

Article  CAS  PubMed  Google Scholar 

Bendele A, McAbee T, Sennello G, Frazier J, Chlipala E, McCabe D. Efficacy of sustained blood levels of interleukin-1 receptor antagonist in animal models of arthritis: comparison of efficacy in animal models with human clinical data. Arthritis Rheum. 1999;42(3):498–506.

Article  CAS  PubMed  Google Scholar 

Bouxsein ML, Boyd SK, Christiansen BA, Guldberg RE, Jepsen KJ, Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res. 2010;25(7):1468–86.

Article  PubMed  Google Scholar 

Bürkner P-C. (2017) brms: An R package for bayesian multilevel models using stan. 2017. 80: 1 28.

Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 2010;8(6): e1000412.

Article  PubMed  PubMed Central  Google Scholar 

Matzelle MM, Gallant MA, Condon KW, Walsh NC, Manning CA, Stein GS, et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum. 2012;64(5):1540–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Montilla-Garcia A, Tejada MA, Perazzoli G, Entrena JM, Portillo-Salido E, Fernandez-Segura E, et al. Grip strength in mice with joint inflammation: a rheumatology function test sensitive to pain and analgesia. Neuropharmacology. 2017;125:231–42.

Article  CAS  PubMed  Google Scholar 

Schuetz P, Wirz Y, Sager R, Christ-Crain M, Stolz D, Tamm M, et al. Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections. Cochrane Database Syst Rev. 2017;10:007498.

Google Scholar 

Talebi-Taher M, Shirani F, Nikanjam N, Shekarabi M. Septic versus inflammatory arthritis: discriminating the ability of serum inflammatory markers. Rheumatol Int. 2013;33(2):319–24.

Article  CAS  PubMed  Google Scholar 

Chouk M, Verhoeven F, Sondag M, Guillot X, Prati C, Wendling D. Value of serum procalcitonin for the diagnosis of bacterial septic arthritis in daily practice in rheumatology. Clin Rheumatol. 2019;38(8):2265–73.

Article  PubMed  Google Scholar 

Becker KL, Snider R, Nylen ES. Procalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target. Br J Pharmacol. 2010;159(2):253–64.

Article  CAS  PubMed  Google Scholar 

Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock. 2000;14(1):73–8.

Article  CAS  PubMed  Google Scholar 

Matera G, Quirino A, Giancotti A, Pulicari MC, Rametti L, Rodriguez ML, et al. Procalcitonin neutralizes bacterial LPS and reduces LPS-induced cytokine release in human peripheral blood mononuclear cells. BMC Microbiol. 2012;12:68.

Article